Erectile Dysfunction and Low Serum Testosterone in Indian Diabetic Men: Prevalence and Risk factors ED and testosterone deficiency in diabetic men
Men's Health Journal,
Vol. 6 No. 1 (2022),
1 Dey 2022
,
Page e11
https://doi.org/10.22037/mhj.v6i1.38748
Abstract
Introduction: Diabetic male patients are more likely to have ED and subnormal testosterone levels than non-diabetic men. We aimed to estimate the prevalence of ED and low serum testosterone level in diabetic men, and to study the patient’s age, duration of diabetes, body mass index (BMI), glycosylated hemoglobin (HbA1c) and spot urine albumin to urine creatinine ratio (uACR) as risk factors for ED, and their correlation with serum total testosterone level. Methods: This was a cross-sectional observational study, including 103 male patients aged 30-60 years, diagnosed with type 2 diabetes mellitus (T2DM). Patients with score less than 22 on the abridged 5-item version of the International Index of Erectile Function (IIEF-5) questionnaire were diagnosed to have ED, and patients with serum total testosterone level less than 2.3ng/ml (8nmol/L) were considered to have low serum testosterone. Results: The prevalence of ED was 46.6%, and that of low testosterone level was 18.4%. Men with ED had significantly higher prevalence of testosterone deficiency than those without ED (31.3% vs 7.3%, P=0.004). Mean age of the patient (50.73±7.22 vs 47.51±8.67 years, P=0.045), mean duration of diabetes (10.66±5.56 vs 8.53±5.60 years, P<0.001), mean BMI (28.51±4.05 vs 24.51±3.32 kg/m2, P<0.001), and mean HbA1c (8.49±1.15 vs 7.70±1.05 %, P<0.001) were higher, while mean total testosterone level (3.18±1.65 vs 4.61±1.92 ng/ml, P<0.001) was lower in patients with ED, compared with those without ED. Total testosterone level negatively correlated with BMI (R=-0.682, P<0.001), HbA1c (R=-0.279, P=0.004), and uACR (R=-0.241, P=0.014); and positively correlated with IIEF-5 questionnaire score (R=0.519, P<0.001). BMI (P<0.001) and uACR (P=0.048) independently and negatively correlated with total testosterone level. Conclusion: ED is a common complication in Indian men with T2DM. Excess weight is a risk factor for ED as well as low testosterone level. Older age, longer duration of DM and poor glycemic control are risk factors for ED, and presence of microalbuminuria is associated with low testosterone level. Serum testosterone levels should be measured in diabetic men suffering from ED.
- Erectile Dysfunction
- Diabetes Mellitus
- Testosterone Deficiency
- Abridged IIEF-5 Questionnaire
- Hypogonadism
How to Cite
References
NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993 Jul;270(1):83-90.
Anwar Z, Sinha V, Mitra S, Mishra AK, Ansari MH, Bharti A, et al. Erectile Dysfunction: An Underestimated Presentation in Patients with Diabetes Mellitus. Indian J Psychol Med. 2017 Sep-Oct;39(5):600-604. doi:10.4103/0253-7176.217015.
Sondhi M, Kakar A, Gogia A, Gupta M (2018). Prevalence of erectile dysfunction in diabetic patients. Current Medicine Research and Practice. 2018;8;88-91. doi:10.1016/J.CMRP.2018.05.005
Kumar DP. Hypogonadism and Erectile Dysfunction in Male Patients of Type 2 DM without CAD and With CAD in Indian Scenario. J Med Sci Clin Res. 2017 Jun 26;05(06):23856–63. doi:10.18535/jmscr/v5i6.175
Ganesh HK, Vijaya Sarathi HA, George J, Shivane VK, Bandgar T, Menon PS, et al. Prevalence of hypogonadism in patients with type 2 diabetes mellitus in an Asian Indian study group. Endocr Pract. 2009 Sep-Oct;15(6):513-20. doi: 10.4158/EP09035.ORR.
Traish AM, Guay AT. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med. 2006 May;3(3):382-404; discussion 404-7. doi: 10.1111/j.1743-6109.2006.00245.x.
Dandona P, Rosenberg MT. A practical guide to male hypogonadism in the primary care setting. Int J Clin Pract. 2010 May;64(6):682-96. doi: 10.1111/j.1742-1241.2010.02355.x.
Ugwu TE, Ikem RT, Kolawole BA, Ezeani IU. Clinicopathologic assessment of hypogonadism in men with type 2 diabetes mellitus. Indian J Endocrinol Metab. 2016 Sep-Oct;20(5):667-673. doi: 10.4103/2230-8210.190554.
Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999 Dec;11(6):319-26. doi: 10.1038/sj.ijir.3900472.
Sasaki H, Yamasaki H, Ogawa K, Nanjo K, Kawamori R, Iwamoto Y, et al. Prevalence and risk factors for erectile dysfunction in Japanese diabetics. Diabetes Res Clin Pract. 2005 Oct;70(1):81-9. doi: 10.1016/j.diabres.2005.02.018.
Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med. 2003 Aug 5;139(3):161-8. doi: 10.7326/0003-4819-139-3-200308050-00005.
Yang G, Pan C, Lu J. Prevalence of erectile dysfunction among Chinese men with type 2 diabetes mellitus. Int J Impot Res. 2010 Sep-Oct;22(5):310-7. doi: 10.1038/ijir.2010.21.
Adegoke AT, Olawale OS., Ehizode EM., Chinedu EE. Erectile Dysfunction among Nigerian Men with Diabetes: a Systematic Review. Men’s Health Journal. 2020;4(1);e23. doi:10.22037/mhj.v4i1.33115.
Abedi AR, Aliakbari F, Mirzababaei M, Safian F, Shojaeefar E. Sexual Dysfunction in Iranian Men with Diabetes; a Systematic Review and Meta-analysis. Men’s Health Journal. 2021;5(1);e11. doi:10.22037/mhj.v5i1.34338.
Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol. 2001 Aug;166(2):569-74; discussion 574-5. doi:10.1016/s0022-5347(05)65986-1.
El Saghier EO, Shebl SE, Fawzy OA, Eltayeb IM, Bekhet LM, Gharib A. Androgen Deficiency and Erectile Dysfunction in Patients with Type 2 Diabetes. Clin Med Insights Endocrinol Diabetes. 2015 Jul 19;8:55-62. doi:10.4137/CMED.S27700.
Corona G, Mannucci E, Petrone L, Ricca V, Balercia G, Mansani R, et al. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res. 2006 Mar-Apr;18(2):190-7. doi:10.1038/sj.ijir.3901391.
Ghazi S, Zohdy W, Elkhiat Y, Shamloul R. Serum testosterone levels in diabetic men with and without erectile dysfunction. Andrologia. 2012 Dec;44(6):373-80. doi:10.1111/j.1439-0272.2012.01292.x.
Aboelnaga M, Elshahawy H. Prevalence and predictors for low total testosterone levels among male type 2 diabetic patients: an Egyptian experience. Int J Res Med Sci. 2016;4(8):3381–7. doi:10.18203/2320-6012.ijrms20162298
Al Hayek AA, Robert AA, Alshammari G, Hakami H, Al Dawish MA. Assessment of Hypogonadism in Men With Type 2 Diabetes: A Cross-Sectional Study From Saudi Arabia. Clin Med Insights Endocrinol Diabetes. 2017 May 19;10:1179551417710209. doi: 10.1177/1179551417710209. Erratum in: Clin Med Insights Endocrinol Diabetes. 2017 Oct 10;10 :1179551417722086.
Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab. 2004 Nov;89(11):5462-8. doi: 10.1210/jc.2004-0804.
Giuliano FA, Leriche A, Jaudinot EO, de Gendre AS. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology. 2004 Dec;64(6):1196-201. doi: 10.1016/j.urology.2004.08.059.
Mahbub MI, Kamrul-Hasan AB, Selim S, Mir AS, Saifuddin M, Pathan MF. Frequency and Predictors of Erectile Dysfunction in Bangladeshi Men with Type 2 Diabetes Mellitus: Experience from a Tertiary Center. Mymensingh Med J. 2019 Jan;28(1):137-143.
Korani MA, Sonbol A. Study of risk factors for erectile dysfunction in patients with type 2 diabetes mellitus: Correlation to serum testosterone level. Alexandria J Med. 2018;54(4):319–21. doi:10.1016/j.ajme.2018.01.002
Zheng H, Fan W, Li G, Tam T. Predictors for erectile dysfunction among diabetics. Diabetes Res Clin Pract. 2006 Mar;71(3):313-9. doi:10.1016/j.diabres.2005.07.011.
Romeo JH, Seftel AD, Madhun ZT, Aron DC. Sexual function in men with diabetes type 2: association with glycemic control. J Urol. 2000 Mar;163(3):788-91.
Hayashino Y, Izumi K, Okamura S, Nishimura R, Origasa H, Tajima N; JDCP study group. Duration of diabetes and types of diabetes therapy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention prospective study 3 (JDCP study 3). J Diabetes Investig. 2017 Mar;8(2):243-249. doi:10.1111/jdi.12550.
Ziaei-Rad M, Vahdaninia M, Montazeri A. Sexual dysfunctions in patients with diabetes: a study from Iran. Reprod Biol Endocrinol. 2010 May 18;8:50. doi:10.1186/1477-7827-8-50.
Yu LW, Kong AP, Tong PC, Tam C, Ko GT, Ho CS, et al. Evaluation of erectile dysfunction and associated cardiovascular risk using structured questionnaires in Chinese type 2 diabetic men. Int J Androl. 2010 Dec;33(6):853-60. doi:10.1111/j.1365-2605.2009.01026.x.
Mirzaei MR, Amini M, Aminorroaya A. The prevalence of hypogonadism in diabetic men in Isfahan Endocrine and Metabolism Research Center, Isfahan, Iran. J Res Med Sci. 2012 Jul;17(7):602-6.
Hofstra J, Loves S, van Wageningen B, Ruinemans-Koerts J, Jansen I, de Boer H. High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment. Neth J Med. 2008 Mar;66(3):103-9.
Fui MN, Dupuis P, Grossmann M. Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl. 2014 Mar-Apr;16(2):223-31. doi:10.4103/1008-682X.122365.
Guzik TJ, Mangalat D, Korbut R. Adipocytokines - novel link between inflammation and vascular function? J Physiol Pharmacol. 2006 Dec;57(4):505-28.
Hasan MJ, Muqueet A, Sharmeen A, Hoque MR. Prevalence of microalbuminuria in relation to glycemic control in type-2 diabetic patients in Mymensingh. Mymensingh Med J. 2015 Jan;24(1):18-24.
- Abstract Viewed: 70 times
- pdf Downloaded: 56 times